Sensorion
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
375 Rue Du Professeur Joseph Blayac, Mon...Phone Number
+33 467207730Website
www.sensorion.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sensorion
Founded in 2009, Sensorion is a clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders. The company's headquartered in Montpellier, France.Explore more
Sensorion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sensorion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sensorion is spiking on competitors!
Sensorion, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sensorion had a recent Job posting/layoffs
Product Launch: Get notified when Sensorion launches new products
Congratulate Masked Content for being promoted to Masked Content at Sensorion
Funding: Get notified immidiatlly once Sensorion has new funding data
Check if Sensorion has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Sensorion recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Sensorion
Find more new buyers
Company Profile Activity
Activity Insights
Sensorion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sensorion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sensorion.
Sensorion financials insights
Gather financial insights about Sensorion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Grant
$10.4M
2024
Other Financing Round
$54.4M
Sensorion Tech Stack
A closer look at the technologies used by Sensorion
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Project
Laboratory Operations, Medical Research, Clinical Operations
Sensorion News & Media
Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced preliminary positive data from the first cohort of the Phase 1/2 Audiogene clinical trial evaluating the low dose of SENS-501, the Company’s gene therapy candidate being developed to treat a specific form of congenital deafness linked to muSensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced its participation at the 28th Annual American Society of Cell and Gene Therapy Meeting (ASGCT), taking place on May 13-17, 2025, in New-Orleans, United States of America. On this occasion, Rafik Boudra, Preclinical Group Leader Technology &Sensorion Announces Presentation by Pr. Natalie Loundon at the 2025 American Society of Pediatric Otolaryngology Annual Meeting
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that Pr. Natalie Loundon, pediatric ENT Surgeon, Director of the Center for Research in Pediatric Audiology, Necker Enfants Malades Hospital, AP-HP, in Paris, France, will make an oral presentation at the annual meeting of the American SociSensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 12, 2025, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sensorion
Sign Up For FreeTo access detailed company insights
Founded in 2009, Sensorion is a clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders. The company's headquartered in Montpellier, France.... Read More
